Importance of oestrogen, xenoestrogen and phytoestrogen metabolism in breast cancer risk

被引：5
|
作者：
Wiseman, H [1 ]
机构：
[1] Kings Coll London, Nutr Food & Hlth Res Ctr, Dept Nutr & Dietet, London W8 7AH, England
来源：
BIOCHEMICAL SOCIETY TRANSACTIONS | 1999年 / 27卷 / 02期
关键词：
D O I：
10.1042/bst0270299
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：299 / 304
页数：6
相关论文
共 50 条
  • [31] An overview of menopausal oestrogen–progestin hormone therapy and breast cancer risk
    S A Lee
    R K Ross
    M C Pike
    [J]. British Journal of Cancer, 2005, 92 : 2049 - 2058
  • [32] Analysis of population characteristics related to the total effective xenoestrogen burden: A biomarker of xenoestrogen exposure in breast cancer
    Fernandez, Mariana F.
    Santa-Marina, Loreto
    Ibarluzea, Jesus M.
    Exposito, Jose
    Aurrekoetxea, Juan J.
    Torne, Pablo
    Laguna, Juan
    Rueda, Ana I.
    Pedraza, Vicente
    Olea, Nicolas
    [J]. EUROPEAN JOURNAL OF CANCER, 2007, 43 (08) : 1290 - 1299
  • [33] Multiple xenoestrogen air pollutants and breast cancer risk: Statistical approaches to investigate combined exposures effect
    Amadou, Amina
    Giampiccolo, Camille
    Ngaleu, Fabiola Bibi
    Praud, Delphine
    Coudon, Thomas
    Grassot, Leny
    Faure, Elodie
    Couvidat, Florian
    Frenoy, Pauline
    Severi, Gianluca
    Mancini, Francesca Romana
    Roy, Pascal
    Fervers, Beatrice
    [J]. ENVIRONMENTAL POLLUTION, 2024, 351
  • [34] Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry
    Work, M. E.
    John, E. M.
    Andrulis, I. L.
    Knight, J. A.
    Liao, Y.
    Mulligan, A. M.
    Southey, M. C.
    Giles, G. G.
    Dite, G. S.
    Apicella, C.
    Hibshoosh, H.
    Hopper, J. L.
    Terry, M. B.
    [J]. BRITISH JOURNAL OF CANCER, 2014, 110 (05) : 1367 - 1377
  • [35] Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry
    M E Work
    E M John
    I L Andrulis
    J A Knight
    Y Liao
    A M Mulligan
    M C Southey
    G G Giles
    G S Dite
    C Apicella
    H Hibshoosh
    J L Hopper
    M B Terry
    [J]. British Journal of Cancer, 2014, 110 : 1367 - 1377
  • [36] An overview of menopausal oestrogen-progestin hormone therapy and breast cancer risk
    Lee, SA
    Ross, RK
    Pike, MC
    [J]. BRITISH JOURNAL OF CANCER, 2005, 92 (11) : 2049 - 2058
  • [37] Premenopausal endogenous oestrogen levels and breast cancer risk: a meta-analysis
    K Walker
    D J Bratton
    C Frost
    [J]. British Journal of Cancer, 2011, 105 : 1451 - 1457
  • [38] FGFR2 risk SNPs confer breast cancer risk by augmenting oestrogen responsiveness
    Campbell, Thomas M.
    Castro, Mauro A. A.
    de Santiago, Ines
    Fletcher, Michael N. C.
    Halim, Silvia
    Prathalingam, Radhika
    Ponder, Bruce A. J.
    Meyer, Kerstin B.
    [J]. CARCINOGENESIS, 2016, 37 (08) : 741 - 750
  • [39] Oestrogen receptor beta (ERβ) polymorphism and its influence on breast cancer risk
    D. Surekha
    K. Sailaja
    D. Nageswara Rao
    D. Raghunadharao
    S. Vishnupriya
    [J]. Journal of Genetics, 2009, 88 : 261 - 266
  • [40] Oestrogen receptor beta (ERβ) polymorphism and its influence on breast cancer risk
    Surekha, D.
    Sailaja, K.
    Rao, D. Nageswara
    Raghunadharao, D.
    Vishnupriya, S.
    [J]. JOURNAL OF GENETICS, 2009, 88 (02) : 261 - 266
12345